JP2016146837A5 - - Google Patents

Download PDF

Info

Publication number
JP2016146837A5
JP2016146837A5 JP2016041230A JP2016041230A JP2016146837A5 JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5 JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5
Authority
JP
Japan
Prior art keywords
seq
recombinant adenovirus
protein
recombinant
immunogenic epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016041230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016146837A (ja
JP6293181B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2009/054212 external-priority patent/WO2011022002A1/en
Application filed filed Critical
Publication of JP2016146837A publication Critical patent/JP2016146837A/ja
Publication of JP2016146837A5 publication Critical patent/JP2016146837A5/ja
Application granted granted Critical
Publication of JP6293181B2 publication Critical patent/JP6293181B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016041230A 2009-08-18 2016-03-03 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 Expired - Fee Related JP6293181B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2009/054212 WO2011022002A1 (en) 2009-08-18 2009-08-18 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
USPCT/US2009/054212 2009-08-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012525677A Division JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Publications (3)

Publication Number Publication Date
JP2016146837A JP2016146837A (ja) 2016-08-18
JP2016146837A5 true JP2016146837A5 (enExample) 2017-02-16
JP6293181B2 JP6293181B2 (ja) 2018-03-14

Family

ID=43607237

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012525677A Expired - Fee Related JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変
JP2016041230A Expired - Fee Related JP6293181B2 (ja) 2009-08-18 2016-03-03 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012525677A Expired - Fee Related JP5947719B2 (ja) 2009-08-18 2010-08-18 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変

Country Status (16)

Country Link
US (1) US20170348405A1 (enExample)
EP (2) EP2467157A4 (enExample)
JP (2) JP5947719B2 (enExample)
KR (1) KR20120094469A (enExample)
CN (2) CN103025349B (enExample)
BR (1) BR112012003808A2 (enExample)
CA (1) CA2769415A1 (enExample)
IL (1) IL217709A (enExample)
MX (1) MX339830B (enExample)
NZ (1) NZ598703A (enExample)
PH (1) PH12012500164A1 (enExample)
RU (1) RU2585228C2 (enExample)
SG (2) SG10201404970PA (enExample)
UA (1) UA108081C2 (enExample)
WO (2) WO2011022002A1 (enExample)
ZA (1) ZA201201286B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154199A1 (en) 2010-10-18 2012-11-15 The Government Of The United States, As Represented By The Secretary Of The Army Soluble recombinant plasmodium falciparum circumsporozoite protein
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
AU2014236207B2 (en) 2013-03-14 2019-05-23 Salk Institute For Biological Studies Oncolytic adenovirus compositions
JP6734651B2 (ja) * 2013-06-03 2020-08-05 ブイエルピー・セラピューティクス・リミテッド・ライアビリティ・カンパニーVLP Therapeutics, LLC マラリアワクチン
MX2018003103A (es) * 2015-09-16 2018-06-11 Artificial Cell Tech Inc Composiciones y procedimientos contra la malaria.
DK3405582T3 (da) * 2016-01-21 2020-11-02 Janssen Vaccines & Prevention Bv Forbedret adenovirusbaseret malaria-vaccine, der koder for og fremviser et malaria-antigen
CA3013637A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
KR102471633B1 (ko) 2016-02-23 2022-11-25 솔크 인스티튜트 포 바이올로지칼 스터디즈 바이러스 동역학에 미치는 영향 최소화를 위한 치료용 아데노바이러스의 외인성 유전자 발현
CN107841513B (zh) * 2016-09-18 2023-04-14 中国科学院上海巴斯德研究所 基于M2e表位的广谱型流感疫苗
CA3045892A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
CN108192876A (zh) * 2017-12-07 2018-06-22 东莞市第八人民医院 一种人3型腺病毒衣壳蛋白同时展示ca16双中和抗原表位疫苗候选株的制备方法和应用
MX2020010499A (es) 2018-04-09 2020-10-28 Salk Inst For Biological Studi Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
WO2020221451A1 (en) * 2019-04-30 2020-11-05 Humabs Biomed Sa Antibodies binding to plasmodium circumsporozoite protein and uses thereof
CN110687289B (zh) * 2019-10-17 2023-04-18 中国人民解放军陆军军医大学 Fgl2蛋白作为疟疾感染标志物的应用
GB201915905D0 (en) * 2019-11-01 2019-12-18 Spybiotech Ltd Viruses with modified capsid proteins
JP2021178021A (ja) * 2020-05-14 2021-11-18 株式会社三洋物産 遊技機
WO2022234276A1 (en) * 2021-05-04 2022-11-10 SpyBiotech Limited Adenoviral vectors and vaccines thereof
CA3233100A1 (en) * 2021-09-23 2023-03-30 Sagittarius Bio, Inc. Adenoviruses and methods for using adenoviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066623A (en) * 1993-11-23 2000-05-23 The United States Of America As Represented By The Secretary Of The Navy Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines
CA2453880A1 (en) * 2001-07-25 2003-02-06 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
US8232255B2 (en) * 2002-10-23 2012-07-31 Glaxosmithkline Biologicals S.A. Methods for vaccinating against malaria
NZ539813A (en) * 2002-12-17 2008-04-30 Crucell Holland Bv A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6
CA2524499A1 (en) * 2003-05-14 2004-11-25 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Broadening adenovirus tropism
JP2005287309A (ja) * 2004-03-31 2005-10-20 Dnavec Research Inc 遺伝子導入を増強するための薬剤および方法
ES2358523T3 (es) * 2004-10-13 2011-05-11 Crucell Holland B.V. Vectores adenovirales mejorados y usos de los mismos.
WO2007027860A2 (en) * 2005-08-31 2007-03-08 Genvec, Inc. Adenoviral vector-based malaria vaccines
US20100272753A1 (en) * 2006-10-26 2010-10-28 The Johns Hopkins University Recombinant Adenovirus Vaccines

Similar Documents

Publication Publication Date Title
JP2016146837A5 (enExample)
SG156535A1 (en) Recombinant viral-based malaria vaccines
IL182357A0 (en) Malaria prime/boost vaccines
UA108081C2 (uk) Модифікація рекомбінантного аденовірусу імуногенними епітопами білка circumsporozoite плазмодія
RU2015135890A (ru) Композиция вакцины
MX2020000221A (es) Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas.
JP2008529558A5 (enExample)
JP2016539946A5 (enExample)
JP2019519252A5 (enExample)
EA200901060A1 (ru) Новый способ и композиции
JP2015096070A5 (enExample)
JP2012501959A5 (enExample)
WO2011138251A8 (en) Lentiviral vector based immunological compounds against malaria
JP2020536489A5 (enExample)
JP2014507146A5 (enExample)
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
Schöne et al. Immunodominance of adenovirus-derived CD8+ T cell epitopes interferes with the induction of transgene-specific immunity in adenovirus-based immunization
JP2014519817A5 (enExample)
JP2010532656A5 (enExample)
ZA201707985B (en) Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
Holanda et al. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection
JP2020509770A5 (enExample)
WO2008086386A3 (en) Adenoviral vector-based malaria vaccines
PH12018502430A1 (en) Vaccines
WO2010128524A8 (en) Combined measles-malaria vaccine